Delhi polls: EC imposes 48-hour campaign ban on BJP's Kapil Mishra over 'India vs Pak' tweet | Anyone who opposes 'MOSH agenda of hate' is urban naxal: Rahul after Bhima-Koregaon case transferred to NIA | Rajasthan becomes third state to pass anti-CAA resolution | Journalist Deepak Chaurasia heckled by Shaheen Bagh protesters, his colleagues condemn the act | Brazil Prez Bolsonaro given ceremonial welcome, External Affairs Minister Jaishankar calls on visiting dignitary |

Lupin launches generic Aricept tablets in the US

India blooms News Service | 31 Mar 2016, 09:23 pm
Mumbai/ Baltimore, Mar 31 (IBNS) Mumbai-based Lupin Limited (Lupin), a transnational pharmaceutical company producing and developing a wide range of branded and generic formulations, biotechnology products and APIs globally, announced on Thursday that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Donepezil Hydrochloride Tablets, 23 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic equivalent of Eisai Inc's Aricept® Tablets, 23mg.
Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. works in the area of generic medicines and branded formulations.
 
Lupin's Donepezil Hydrochloride Tablets, 23 mg are the AB rated generic equivalent of Eisai Inc's Aricept® Tablets, 23mg. It is indicated for the treatment of dementia of the Alzheimer's type.
 
Aricept® had US sales of USD 47.1 million (IMS MAT December 2015).

Lupin launches generic Aricept tablets in the US

India blooms News Service
Comments ()

Post your comment:

Loading...
Web Analytics